A multicenter randomized, double‐blind, placebo‐controlled, parallel‐group study to evaluate the effects of a 1‐year regimen of orally inhaled fluticasone furoate 50 µg once daily on growth velocity in prepubertal, pediatric participants with well‐controlled asthma
Pediatric Pulmonology · 2023
DOI: 10.1002/ppul.26679 ↗At a glance
Randomisierte kontrollierte Studie in Pediatric Pulmonology, 2023. Written by Philippe Bareille and 6 co-authors. Institution: GSK, Stevenage, UK. Major MEDLINE topics: Bronchodilator Agents, Asthma. Cited 2 times so far (Crossref); 29 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: GSK.
Abstract (original language)
Introduction : Growth impairment is a known adverse event (AE) of corticosteroids in children. This study aimed to assess the effect of once‐daily (QD) inhaled fluticasone furoate (FF) versus placebo on growth velocity over 1 year in prepubertal children with well‐controlled asthma. Materials and Methods : This randomized, double‐blind, parallel‐group, placebo‐controlled, multicenter study (NCT02889809) included prepubertal children, aged 5 to
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- GSK, Stevenage, UK.
- GSK, Brentford, London, UK.
- Alergo-Med Specialist Medical Clinic, Tarnów, Poland.
- Parexel International, Paris, France.
ORCID profiles: Philippe Bareille, Varsha Imber
Funding
- GSK
Cite
APA
Bareille, P., Imber, V., Crawford, J., Majorek-Olechowska, B., Karam-Absi, Z., Stone, S., & Birk, R. (2023). A multicenter randomized, double‐blind, placebo‐controlled, parallel‐group study to evaluate the effects of a 1‐year regimen of orally inhaled fluticasone furoate 50 µg once daily on growth velocity in prepubertal, pediatric participants with well‐controlled asthma. Pediatric Pulmonology. https://doi.org/10.1002/ppul.26679
Vancouver
Bareille P, Imber V, Crawford J, Majorek-Olechowska B, Karam-Absi Z, Stone S, et al. A multicenter randomized, double‐blind, placebo‐controlled, parallel‐group study to evaluate the effects of a 1‐year regimen of orally inhaled fluticasone furoate 50 µg once daily on growth velocity in prepubertal, pediatric participants with well‐controlled asthma. Pediatric Pulmonology. 2023. doi:10.1002/ppul.26679
BibTeX
@article{Bareille2023,
author = {Bareille, Philippe and Imber, Varsha and Crawford, Jodie and Majorek-Olechowska, Bernadetta and Karam-Absi, Zeina and Stone, Sally and Birk, Ruby},
title = {A multicenter randomized, double‐blind, placebo‐controlled, parallel‐group study to evaluate the effects of a 1‐year regimen of orally inhaled fluticasone furoate 50 µg once daily on growth velocity in prepubertal, pediatric participants with well‐controlled asthma},
journal = {Pediatric Pulmonology},
year = {2023},
doi = {10.1002/ppul.26679}
}
EUVIMED